KURA
Price
$10.65
Change
-$0.00 (-0.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
943.87M
27 days until earnings call
Intraday BUY SELL Signals
MIRM
Price
$82.93
Change
-$0.99 (-1.18%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
5.71B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs MIRM

KURA vs MIRM Comparison Chart in %
View a ticker or compare two or three
VS
KURA vs. MIRM commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and MIRM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KURA vs MIRM: Fundamental Ratings
KURA
MIRM
OUTLOOK RATING
1..100
7165
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
10031
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5463
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (64) in the Biotechnology industry is in the same range as MIRM (69) in the null industry. This means that KURA’s stock grew similarly to MIRM’s over the last 12 months.

MIRM's Profit vs Risk Rating (31) in the null industry is significantly better than the same rating for KURA (100) in the Biotechnology industry. This means that MIRM’s stock grew significantly faster than KURA’s over the last 12 months.

KURA's SMR Rating (99) in the Biotechnology industry is in the same range as MIRM (100) in the null industry. This means that KURA’s stock grew similarly to MIRM’s over the last 12 months.

KURA's Price Growth Rating (54) in the Biotechnology industry is in the same range as MIRM (63) in the null industry. This means that KURA’s stock grew similarly to MIRM’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MIRM (100) in the null industry. This means that KURA’s stock grew similarly to MIRM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURAMIRM
RSI
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
62%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (KURA: $10.65 vs. MIRM: $83.92)
Brand notoriety: KURA and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 115% vs. MIRM: 98%
Market capitalization -- KURA: $943.87M vs. MIRM: $5.71B
KURA [@Biotechnology] is valued at $943.87M. MIRM’s [@Biotechnology] market capitalization is $5.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 0 FA rating(s) are green while MIRM’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 0 green, 5 red.
  • MIRM’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 3 TA indicator(s) are bullish while MIRM’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 3 bullish, 7 bearish.
  • MIRM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than KURA.

Price Growth

KURA (@Biotechnology) experienced а -1.93% price change this week, while MIRM (@Biotechnology) price change was -6.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.58%. For the same industry, the average monthly price growth was -14.40%, and the average quarterly price growth was -1.79%.

Reported Earning Dates

KURA is expected to report earnings on Oct 29, 2026.

MIRM is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-3.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KURA
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDVY40.970.39
+0.96%
First Trust SMID Cap Rising Dividend Achievers ETF (SDVY)
NVIT51.470.25
+0.48%
YieldMax NVDA Performance & Distribution Target 25 ETF (NVIT)
BNOV49.100.14
+0.29%
Innovator U.S. Equity Buffer ETF - November (BNOV)
DYFI22.200.01
+0.04%
IDX Dynamic Fixed Income ETF (DYFI)
FYLD39.31-0.23
-0.58%
Cambria Foreign Shareholder Yield ETF (FYLD)

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with IMVT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-0.56%
IMVT - KURA
53%
Loosely correlated
-0.38%
XNCR - KURA
52%
Loosely correlated
-0.72%
KYTX - KURA
49%
Loosely correlated
-4.12%
RLAY - KURA
48%
Loosely correlated
+2.44%
VIR - KURA
48%
Loosely correlated
+0.98%
More

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with PCVX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
-1.82%
PCVX - MIRM
45%
Loosely correlated
-1.49%
XERS - MIRM
45%
Loosely correlated
-3.24%
EXEL - MIRM
41%
Loosely correlated
-0.80%
KURA - MIRM
40%
Loosely correlated
-0.56%
PTCT - MIRM
39%
Loosely correlated
-1.00%
More